Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oshkosh | OSK | Nov 22, 2024 | 111.81 | +2.27 |
OSI Systems | OSIS | Nov 22, 2024 | 164.91 | -0.25 |
Osisko Development | ODV | Nov 22, 2024 | 1.84 | -3.16 |
Osisko Gold Royalties | OR | Nov 22, 2024 | 20.11 | +1.26 |
Ostin Technology Group | OST | Nov 22, 2024 | 0.22 | +0.46 |
Otis Worldwide | OTIS | Nov 22, 2024 | 101.20 | +1.25 |
Otter Tail | OTTR | Nov 22, 2024 | 80.78 | +0.25 |
Ouster | OUST | Nov 22, 2024 | 9.53 | +6.24 |
Outbrain | OB | Nov 22, 2024 | 5.05 | -0.98 |
Outfront Media | OUT | Nov 22, 2024 | 19.13 | +1.00 |
Outlook Therapeutics | OTLK | Nov 22, 2024 | 5.03 | -1.95 |
Outset Medical | OM | Nov 22, 2024 | 0.84 | +10.15 |
Ovid Therapeutics | OVID | Nov 22, 2024 | 1.05 | -0.94 |
Ovintiv | OVV | Nov 22, 2024 | 46.71 | +0.26 |
Owens & Minor | OMI | Nov 22, 2024 | 12.35 | +0.98 |
Owens Corning | OC | Nov 22, 2024 | 202.77 | +2.63 |
Owlet A | OWLT | Nov 22, 2024 | 4.62 | +1.54 |
Oxbridge Re | OXBR | Nov 22, 2024 | 3.05 | -1.29 |
Oxford Industries | OXM | Nov 22, 2024 | 77.80 | +2.03 |
Oxford Lane Capital | OXLC | Nov 22, 2024 | 5.22 | +0.19 |
Oxford Lane Capital 2027 Pref | OXLCP | Nov 22, 2024 | 24.08 | +0.00 |
Oxford Square Capital | OXSQ | Nov 22, 2024 | 2.62 | -0.76 |
P.A.M. Transportation Services | PTSI | Nov 22, 2024 | 19.72 | 0.00 |
P10 | PX | Nov 22, 2024 | 13.79 | +1.40 |
P3 Health Partners A | PIII | Nov 22, 2024 | 0.21 | -0.93 |
PACCAR | PCAR | Nov 22, 2024 | 114.75 | +0.61 |
Pacific Biosciences of California | PACB | Nov 22, 2024 | 1.80 | +1.69 |
Pacific ETF FTSE Vanguard | VPL | Nov 22, 2024 | 74.09 | +0.45 |
Pacific Ex-Japan MSCI Ishares | EPP | Nov 22, 2024 | 47.24 | -0.06 |
Pacific Gas & Electric | PCG | Nov 22, 2024 | 21.37 | +0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.